CFR

Used Nuclear Fuel Recycling Agreement Signed by Orano and SHINE Technologies

Retrieved on: 
Thursday, February 29, 2024

BETHESDA, Md., Feb. 29, 2024 /PRNewswire/ -- Orano and SHINE Technologies signed a Memorandum of Understanding (MOU) this week to cooperate in the development of a U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from light water reactors.

Key Points: 
  • BETHESDA, Md., Feb. 29, 2024 /PRNewswire/ -- Orano and SHINE Technologies signed a Memorandum of Understanding (MOU) this week to cooperate in the development of a U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from light water reactors.
  • "For this initiative with SHINE, we bring more than 55 years of experience transporting and recycling used nuclear fuel in France and managing used fuel in the U.S."
    "Our goal is to stand up an operational pilot facility by the early 2030s.
  • "It is time for the U.S. to seriously consider recycling used nuclear fuel," said Jean-Luc Palayer, CEO of Orano USA.
  • Recycling used nuclear fuel into useful products will significantly reduce the mass, volume, and toxicity of the remaining nuclear material for permanent disposal.

Argus launches first Canadian CFR road fuel spot price assessments

Retrieved on: 
Thursday, February 29, 2024

HOUSTON, Feb. 29, 2024 /PRNewswire/ -- Global energy and commodity price reporting agency Argus has launched a Canadian Clean Fuel Regulation (CFR) spot market assessment to bring new price transparency to the supply chain and enable fuel manufacturers to understand the cost of complying with environmental legislation for each litre of gasoline or diesel they sell.

Key Points: 
  • HOUSTON, Feb. 29, 2024 /PRNewswire/ -- Global energy and commodity price reporting agency Argus has launched a Canadian Clean Fuel Regulation (CFR) spot market assessment to bring new price transparency to the supply chain and enable fuel manufacturers to understand the cost of complying with environmental legislation for each litre of gasoline or diesel they sell.
  • The new daily price represents the first assessment of the Canadian CFR market underpinned by traditional survey assessment methodology.
  • Argus Media chairman and chief executive Adrian Binks said: "The significant changes under way in low carbon fuel standard (LCFS) programs in North America make Argus price assessments, news and analysis of these markets essential.
  • It assesses the Canadian CFR market and offers four quarters of pricing for California's LCFS and Oregon's Clean Fuels Program.

Onboard Systems Announces Blackcomb Helicopters as Canadian Launch Customer for Forthcoming Medium Bell HEC Dual Cargo Hook System

Retrieved on: 
Wednesday, February 28, 2024

VANCOUVER, BC, Feb. 28, 2024 /PRNewswire/ -- Onboard Systems International, LLC, a leading provider of innovative helicopter cargo hook equipment, announced that Blackcomb Helicopters LP of British Columbia, Canada, has committed to purchase four Medium Bell HEC Dual Cargo Hook Systems at the 2024 HAI Heli-Expo in Anaheim, California.

Key Points: 
  • VANCOUVER, BC, Feb. 28, 2024 /PRNewswire/ -- Onboard Systems International, LLC, a leading provider of innovative helicopter cargo hook equipment, announced that Blackcomb Helicopters LP of British Columbia, Canada, has committed to purchase four Medium Bell HEC Dual Cargo Hook Systems at the 2024 HAI Heli-Expo in Anaheim, California.
  • Onboard's Medium Bell HEC Dual Cargo Hook System is in development and is expected to receive FAA and Transport Canada STC certification by the end of 2024.
  • "In addition to the recently developed Bell 429 HEC system, we've had numerous operators request a medium Bell dual cargo hook HEC system," said Mike Fox, Vice President of Sales & Marketing at Onboard Systems.
  • Onboard's new medium Bell HEC Dual Cargo Hook System will be certified to meet the requirements of 14 CFR 29.865 for Human External Cargo (HEC) for the Bell 204B, Bell 205A, Bell 212, Bell 412, and UH-1 models.

Inovaare's genAI Usher 2.0 Improves Health Plan Efficiencies

Retrieved on: 
Tuesday, February 20, 2024

MILPITAS, Calif., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Inovaare Corporation, an industry-leading healthcare compliance and operations management health-cloud platform provider, today unveiled Usher 2.0, an enhanced version of its generative AI Compliance Assistant. Usher is designed to simplify the complex compliance processes required within the healthcare industry. The new enhancements elevate the health plan employee experience and streamline regulatory adherence through the latest innovations in generative AI.

Key Points: 
  • MILPITAS, Calif., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Inovaare Corporation, an industry-leading healthcare compliance and operations management health-cloud platform provider, today unveiled Usher 2.0, an enhanced version of its generative AI Compliance Assistant.
  • Usher is designed to simplify the complex compliance processes required within the healthcare industry.
  • The new enhancements elevate the health plan employee experience and streamline regulatory adherence through the latest innovations in generative AI.
  • "Our goal is to improve health plan employee experience by simplifying compliance management processes so they are more empowered to drive operational excellence."

E-Cite to Include Gas Powered Options for Both Its GT and C3 Sports Cars Along with Current Electric Versions

Retrieved on: 
Tuesday, February 13, 2024

BOTHELL, WA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – VaporBrands International, Inc. dba E-Cite Motors Group, (OTC:VAPR) reveals that it will offer gas powered versions of its “GT” and “C3” mid-engine sports car models previously only to be available as all electric. 

Key Points: 
  • BOTHELL, WA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – VaporBrands International, Inc. dba E-Cite Motors Group, (OTC:VAPR) reveals that it will offer gas powered versions of its “GT” and “C3” mid-engine sports car models previously only to be available as all electric.
  • Both models will be available with gasoline internal combustion engines (ICE) and current electric (EV) options.
  • The petrol-powered version of the GT will bear the designation of “IC-GT” and the electric version the “EV-GT”, whereas the C3 model “IC-C3” and “EV-C3” respectively.
  • Note* E-Cite's vehicles are in no way categorized as "Kit Cars" as they are manufactured new vehicles.

U.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense® for Early-Stage Breast Cancer

Retrieved on: 
Tuesday, January 30, 2024

CAESAREA, Israel, Jan. 30, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced the U.S. Food and Drug Administration ("FDA") has responded affirmatively to the Company's request for supervisory review ("Appeal") under 21 CFR 10.75 regarding the FDA's prior denial of IceCure's De Novo Classification Request for treating patients with early-stage, low risk breast cancer.

Key Points: 
  • The FDA determined there is sufficient basis to reopen the De Novo file and requested IceCure to submit the full 5-year dataset from the Company's ICE3 trial.
  • The final ICE3 study patient is expected to complete her 5-year follow up examination by the end of February 2024.
  • Additionally, the FDA requested that IceCure submit an analysis of the ICE3 results compared with data from the LUMINA study.
  • A full peer-reviewed article on LUMINA results was published in August 2023, while FDA review of IceCure's De Novo request was underway.

E-Cite Solidifies Design and Rights to Produce the “EV-C3”, a New American EV Sports Car Resembling One of the Most Iconic Vehicles in History, Registers With NHTSA for Use on Public Roads in the US

Retrieved on: 
Thursday, January 18, 2024

The new sports car utilizes more than 90% of the existing engineered E-Cite “EV-GT” sports car currently working on receiving final approval from CARB.

Key Points: 
  • The new sports car utilizes more than 90% of the existing engineered E-Cite “EV-GT” sports car currently working on receiving final approval from CARB.
  • Some of these shared components are a lengthened version of the modular chassis, batteries, drive train, suspension, glass, and more than 50% of the body panels.
  • This allows E-Cite to produce its own VINs for the production of new vehicles.
  • Note* E-Cite's vehicles are in no way categorized as "Kit Cars" as they are manufactured new vehicles.

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows

Retrieved on: 
Wednesday, January 17, 2024

To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software , a first-of-its-kind automation solution designed to connect and integrate workflows across multiple Thermo Fisher Scientific cell therapy instruments while enabling cGMP compliance.

Key Points: 
  • To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software , a first-of-its-kind automation solution designed to connect and integrate workflows across multiple Thermo Fisher Scientific cell therapy instruments while enabling cGMP compliance.
  • View the full release here: https://www.businesswire.com/news/home/20240117931916/en/
    Gibco Cell Therapy Systems (CTS) Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing.
  • By establishing an automated workflow across multiple stages of cell therapy manufacturing, CTS Cellmation Software helps enable traceability, repeatability and 21 CFR Part 11 compliance with secured data connectivity.
  • At present, CTS Cellmation Software connects core Thermo Fisher Scientific cell therapy instruments, including solutions from our Gibco CTS portfolio.

CULLEN/FROST BANKERS ANNOUNCES ADDITION OF HOPE ANDRADE TO BOARD OF DIRECTORS

Retrieved on: 
Friday, January 26, 2024

SAN ANTONIO, Jan. 26, 2024 /PRNewswire/ -- The board of directors of Cullen/Frost Bankers, Inc. (NYSE: CFR) announced that Hope Andrade has been elected to the board.

Key Points: 
  • SAN ANTONIO, Jan. 26, 2024 /PRNewswire/ -- The board of directors of Cullen/Frost Bankers, Inc. (NYSE: CFR) announced that Hope Andrade has been elected to the board.
  • Andrade will join the board's Audit and Risk committees.
  • "We're fortunate to add someone of Hope's experience and prestige to our board of directors," said Phil Green, Cullen/Frost Chairman and CEO.
  • In addition, Andrade has served as chair of the San Antonio Chamber of Commerce and the Hispanic Chamber of Commerce.

Scispot Introduces Lab Operating System and GLUE on AWS Marketplace

Retrieved on: 
Thursday, January 18, 2024

KITCHENER, ON, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Scispot, a leading provider of biotech tech stack, today announced the availability of its products, Lab Operating System (OS) and GLUE, on AWS Marketplace.

Key Points: 
  • KITCHENER, ON, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Scispot, a leading provider of biotech tech stack, today announced the availability of its products, Lab Operating System (OS) and GLUE, on AWS Marketplace.
  • Biotech companies will now have the option to purchase a Scispot license leveraging their Amazon Web Services (AWS) credits and pre-negotiated contracts with AWS.
  • Scispot GLUE provides a scientific data and instrument connectivity toolkit to streamline lab instrument integration and render R&D data AI-ready.
  • Scispot listing on AWS Marketplace provide AWS biotech customers with:
    A quicker approach to harmonize their R&D data utilizing their existing AWS budget.